Designing and interpreting HIV noninferiority trials in naive and experienced patients
- 11 May 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 22 (8), 913-921
- https://doi.org/10.1097/qad.0b013e3282f5556d
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- A new approach for ‘deep salvage’ trials in advanced HIV infectionAIDS, 2007
- Drug Development Strategies for Salvage Therapy: Conflicts and SolutionsAIDS Research and Human Retroviruses, 2006
- An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adultsAIDS, 2006
- Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trialCurrent Medical Research and Opinion, 2005
- Special Invited Papers Section: Therapeutic Equivalence – Clinical Issues and Statistical Methodology in Noninferiority TrialsBiometrical Journal, 2005
- Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral‐Naive HIV‐Infected AdultsClinical Infectious Diseases, 2004
- Once-Daily versus Twice-Daily Lamivudine, in Combination with Zidovudine and Efavirenz, for the Treatment of Antiretroviral-Naive Adults with HIV Infection: A Randomized Equivalence TrialClinical Infectious Diseases, 2004
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004
- Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 InfectionThe New England Journal of Medicine, 2004
- Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse‐Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1–Infected Protease Inhibitor–Experienced PatientsThe Journal of Infectious Diseases, 2002